JPWO2023190176A5 - - Google Patents
Info
- Publication number
- JPWO2023190176A5 JPWO2023190176A5 JP2024512364A JP2024512364A JPWO2023190176A5 JP WO2023190176 A5 JPWO2023190176 A5 JP WO2023190176A5 JP 2024512364 A JP2024512364 A JP 2024512364A JP 2024512364 A JP2024512364 A JP 2024512364A JP WO2023190176 A5 JPWO2023190176 A5 JP WO2023190176A5
- Authority
- JP
- Japan
- Prior art keywords
- glycero
- formula
- carbon atoms
- group
- phosphoglycerol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022051918 | 2022-03-28 | ||
| PCT/JP2023/011850 WO2023190176A1 (ja) | 2022-03-28 | 2023-03-24 | 脾臓組織へ核酸を送達するための脂質ナノ粒子およびこれを用いて脾臓組織へ核酸を送達する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023190176A1 JPWO2023190176A1 (cg-RX-API-DMAC7.html) | 2023-10-05 |
| JPWO2023190176A5 true JPWO2023190176A5 (cg-RX-API-DMAC7.html) | 2026-03-19 |
Family
ID=88201471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024512364A Pending JPWO2023190176A1 (cg-RX-API-DMAC7.html) | 2022-03-28 | 2023-03-24 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20260115316A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4501360A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2023190176A1 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240163154A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118973614A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3247039A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023190176A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117778533B (zh) * | 2023-12-30 | 2025-01-07 | 北京剂泰医药科技有限公司 | 核酸脂质纳米颗粒复合物中核酸的定量检测方法 |
| CN118949071A (zh) * | 2024-08-02 | 2024-11-15 | 中国科学院动物研究所 | 一种掺杂金属离子佐剂的脾脏靶向mRNA疫苗及其制备方法与应用 |
| CN120757505B (zh) * | 2025-09-08 | 2025-11-21 | 联合钠米(天津)科技有限公司 | 一种二烃基咪唑仿生型脂质化合物及其制备方法和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2702103A1 (en) * | 2007-10-12 | 2009-04-16 | Novosom Ag | Improvements in or relating to amphotaric liposomes comprising neutral lipids |
| WO2013073480A1 (ja) | 2011-11-18 | 2013-05-23 | 日油株式会社 | 細胞内動態を改善したカチオン性脂質 |
| JP6682856B2 (ja) | 2015-01-30 | 2020-04-15 | 株式会社三洋物産 | 遊技機 |
| JP7332478B2 (ja) * | 2017-03-15 | 2023-08-23 | モデルナティエックス インコーポレイテッド | 脂質ナノ粒子製剤 |
| WO2018237369A2 (en) * | 2017-06-23 | 2018-12-27 | Vical Incorporated | Lipid nanoparticle (lnp)-mediated delivery of a crispr-expressing plasmid dna for treating chronic hepatitis b virus infection |
| CA3094057C (en) | 2018-03-27 | 2025-04-08 | Nof Corporation | CATIONIC LIPID WITH IMPROVED INTRACELLULAR DYNAMICS |
| AU2020232790A1 (en) * | 2019-03-06 | 2021-09-16 | Generation Bio Co. | Non-active lipid nanoparticles with non-viral, capsid free DNA |
| CN114929205B (zh) * | 2019-09-06 | 2024-09-03 | 世代生物公司 | 包括末端封闭式dna和可切割脂质的脂质纳米颗粒组合物及其使用方法 |
| WO2021060440A1 (ja) * | 2019-09-26 | 2021-04-01 | 日油株式会社 | 脂質ナノ粒子の凍結乾燥組成物 |
| US12534435B2 (en) | 2020-03-27 | 2026-01-27 | Generation Bio Co. | Lipids and nanoparticle compositions thereof |
-
2023
- 2023-03-24 JP JP2024512364A patent/JPWO2023190176A1/ja active Pending
- 2023-03-24 EP EP23780186.5A patent/EP4501360A4/en active Pending
- 2023-03-24 CN CN202380031620.9A patent/CN118973614A/zh active Pending
- 2023-03-24 US US18/852,363 patent/US20260115316A1/en active Pending
- 2023-03-24 WO PCT/JP2023/011850 patent/WO2023190176A1/ja not_active Ceased
- 2023-03-24 CA CA3247039A patent/CA3247039A1/en active Pending
- 2023-03-24 KR KR1020247035352A patent/KR20240163154A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Heyes et al. | Synthesis and characterization of novel poly (ethylene glycol)-lipid conjugates suitable for use in drug delivery | |
| USRE45195E1 (en) | Compositions and methods for enhancing contrast in imaging | |
| JP4885715B2 (ja) | イリノテカン製剤 | |
| AU2009302042A1 (en) | Liposomal systems comprising sphingomyelin | |
| CN108024960A (zh) | 含有阴离子药物的药物组合物及其制备方法 | |
| KR101925507B1 (ko) | 조절 약물 방출 리포솜 조성물 | |
| US20150283077A1 (en) | Controlled release hydrogels | |
| AU2003270102B2 (en) | Non-vesicular cationic lipid formulations | |
| US20120003159A1 (en) | Compositions and methods for enhancing contrast in imaging | |
| CN113908288A (zh) | 一种mRNA递送系统及其制备方法和应用 | |
| JP5142313B2 (ja) | ポリサルコシン誘導体及びこれを膜構成成分とする薬物担体 | |
| KR102911928B1 (ko) | 신규 이온화 가능한 지질 및 이를 포함하는 지질나노입자 | |
| IL299155B1 (en) | Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof | |
| WO2025172284A1 (en) | Lipids for nanoparticle delivery platform | |
| Seo et al. | Positron emission tomography imaging of the stability of Cu-64 labeled dipalmitoyl and distearoyl lipids in liposomes | |
| JP4833836B2 (ja) | リポソーム製剤 | |
| KR20140036338A (ko) | 표적지향형 난용성 약물 전달체 | |
| JP2006519262A (ja) | リポソームにより誘導される補体活性化の減少のためのリポソーム組成物 | |
| WO2002098465A2 (en) | Cell penetrating therapeutic agents | |
| CA2595485A1 (en) | Liposomal compositions for parenteral delivery of statins | |
| JPWO2005021012A1 (ja) | ゲムシタビン封入薬剤担体 | |
| WO2019161325A1 (en) | Radiation-triggered liposomes | |
| JP2022532075A5 (cg-RX-API-DMAC7.html) | ||
| JPWO2023054241A5 (cg-RX-API-DMAC7.html) | ||
| WO2023054241A1 (ja) | 核酸を脳組織に送達するために用いられる脂質ナノ粒子 |